Author's email address M. L. J. Ashford: firstname.lastname@example.org
Leptin activates ATP-sensitive potassium channels in the rat insulin-secreting cell line, CRI-G1
Article first published online: 30 SEP 2004
The Journal of Physiology
Volume 504, Issue 3, pages 527–535, November 1997
How to Cite
Harvey, J., McKenna, F., Herson, P. S., Spanswick, D. and Ashford, M. L. J. (1997), Leptin activates ATP-sensitive potassium channels in the rat insulin-secreting cell line, CRI-G1. The Journal of Physiology, 504: 527–535. doi: 10.1111/j.1469-7793.1997.527bd.x
- Issue published online: 30 SEP 2004
- Article first published online: 30 SEP 2004
- Received 14 April 1997; accepted 22 July 1997.
- 1Whole-cell current-clamp recordings demonstrate that leptin (0.3–10 nm) hyperpolarizes CRI-G1 insulin-secreting cells. This effect is slow on onset and is not reversed on washout of the leptin.
- 2Voltage-clamp recordings indicate that leptin activates a potassium conductance in the presence of intracellular ATP (5 mm), but has no effect in its absence. Following activation of ATP-sensitive K+ (KATP) current by diazoxide (0.2 mm), addition of leptin did not alter cell membrane potential or potassium current further.
- 3The leptin-induced hyperpolarization and increased potassium conductance are completely inhibited by the application of the sulphonylureas tolbutamide (100 μm) and glibenclamide (0.5 μm).
- 4Cell-attached and inside-out single-channel recordings indicate that leptin activates tolbutamide-sensitive KATP channels in CRI-G1 insulin-secreting cells.
Recent studies indicate that the ob gene product, leptin, is produced exclusively in adipose tissue (Masuzaki et al. 1995) and that in ob/ob mice there is a defect in the ob gene that results in abnormal leptin production and consequent development of severe obesity and diabetes (Zhang, Proenca, Maffei, Barone, Leopold & Friedman, 1994). The db gene encodes the leptin receptor, which in db/db mice has a point mutation resulting in alternative splicing of the coding region and the insertion of a premature termination signal, resulting in leptin insensitivity and the obese, diabetic phenotype (Lee et al. 1996). Consequently, leptin administration to db/db mice has no effect on feeding behaviour and does not normalize the metabolic status of these animals (Campfield, Smith, Guisez, Devos & Burn, 1995; Halaas et al. 1995; Stephens et al. 1995), but administration of leptin to ob/ob mice results in reduced body weight, percentage body fat, food intake and serum concentrations of glucose and insulin (Campfield et al. 1995; Halaas et al. 1995; Pelleymounter et al. 1995; Stephens et al. 1995). It is notable that the changes in glucose and insulin levels induced by leptin administration to ob/ob mice precede any effect on body weight.
Although a central hypothalamic site of action has been postulated for the effects of leptin on food intake and weight loss (Jacob et al. 1997), there is also considerable evidence for direct effects on peripheral tissues, including pancreatic β-cells. Leptin receptor mRNA has been shown to be expressed in rat primary pancreatic islets, the insulinoma cell line βTC-3 (Keiffer, Heller & Habener, 1996) and ob/ob and wild-type mouse pancreatic islets (Emilsson, Liu, Cawthorne, Morton & Davenport, 1997). The latter study also demonstrated that leptin produced a dose-dependent inhibition of glucose-stimulated insulin secretion from isolated islets of ob/ob but not db/db mice. The present study shows that leptin activates ATP-sensitive K+ (KATP) channels to hyperpolarize CRI-G1 insulin-secreting cells, an action consistent with inhibition of insulin release.
Cells from the insulin-secreting cell line CBI-G1 were grown in Dulbecco's modified Eagle's medium with sodium pyruvate and glucose, supplemented with 1o% (v/v) fetal calf serum and 1% (v/v) penicillin and streptomycin at 37°C in a humidified atmosphere of 95% o2 and 5% Co2. Cells were passaged at 2-5 day intervals as previously described (Carrington, Rubery, Pearson & Hales, 1986), plated onto 3.5 cm Petri dishes (Falcon 3oo1) and used 1-4 days after plating.
Electrophysiological recording and analysis
Experiments were performed using whole-cell current- and voltage-clamp recording configurations to monitor membrane potential and macroscopic current, respectively, with the cell-attached and outside-out configurations used to examine single-channel responses. Recording electrodes were pulled from borosilicate glass capillaries and had a resistance of 8–12 MΩ for cell-attached recordings and 1-5MΩ for whole-cell and outside-out experiments when filled with electrolyte solution. Currents and voltages were measured using List EPC-7 or Axopatch 200B amplifiers. Data were recorded onto digital audio tape and replayed for illustration onto a Gould TA 24o chart recorder.
The potential across the membrane is expressed using the usual sign convention, negative inside, and all inward currents, from extra- to intracellular, are shown as downward deflections. Whole-cell experiments were maintained in current-clamp mode to monitor cell resting membrane potential with short excursions into voltage-clamp mode to examine macroscopic current-voltage relationships. In voltage-clamp recordings the membrane potential was held at −50 mV and 10 mV steps of 100 ms duration every 200 ms applied (range of voltages, −120 to −30 mV). In some current-clamp experiments where no voltage-clamp excursions were used, hyperpolarizing current pulses (20 pA and 0.2 s duration) were applied every 5 s to monitor input conductance changes. All values in the text are expressed as means ±s.e.m. Statistical significance between data sets was tested using Student's paired t test.
For whole-cell and outside-out experiments, the pipette solution contained (mm): 140 KCl, 0.6 MgCl2, 3.95 CaCl2, 5.0 EGTA, 5.0 or 1.0 ATP and 10 Hepes (pH 7.2; free [Ca2+] of 1 μm), or an identical solution but with 2.73 CaCl2 and 10 EGTA (free [Ca2+] of 100 nm), and the bath solution consisted of normal saline (mm): 135 NaCl, 5 KCl, 1 MgCl2, 1 GaCl2 and 10 Hepes (pH 7.4). The pipette solution for cell-attached (and inside-out) single channel recordings contained (mm): 140 KCl, 1 CaCl2 1 MgCl2 and 10 Hepes; pH 7.2. The data were analysed for current amplitude, average current activity (I=NfPoi, where Nf is the number of functional channels and Po is the open state probability) and Po, as described previously (Lee, Rowe & Ashford, 1995). All solution changes were achieved by superfusing the bath with a gravity feed system at a rate of 10 ml min−1, which allowed complete bath exchange within 2 min. All experiments were performed at room temperature (22–25°C). ATP, tolbutamide, glibenclamide and diazoxide were obtained from Sigma (UK) and tolbutamide and glibenclamide made up as 100 mm stock solutions in DMSo, and diazoxide as a stock solution in 0.1 m KoH. ATP was made up as a 100 mm stock solution in 10 mm Hepes at pH 7.2 and kept at −4°C until required. Human recombinant leptin was supplied by Dr Peter Lind of Pharmacia-Upjohn (Stockholm, Sweden) and was prepared as a 1 μm stock solution in normal saline and further diluted in normal saline containing 0.2 % (w/v) bovine serum albumin as a carrier.
Under current-clamp conditions with 5 him ATP present in the electrode solution (to maintain the ATP-sensitive potassium (KATP) channels in the closed state during whole-cell perfusion of the cell interior), the mean resting membrane potential of CRI-G1 insulinoma cells was −39 ± 10.1 mV (n= 40). Following application of leptin (1–10 nm), all cells examined to date (n= 42) have responded by hyper-polarization (regardless of whether 0.1 or 1.0 μm Ca2+ was present in the pipette). For example, application of 1o nsi leptin (Fig. 1B) resulted in CEI-G1 cell hyperpolarization to −74 ± 4.9 mV (n= 8), an effect not reversed following wash of the leptin from the bath (n= 3; after 50 min the cells were still hyper polarized). The hyperpolarizing response to leptin is slow, taking 7–8 min before initiation of response and a further 8-10 min to achieve a maximum. This slow response is not dependent upon the concentration of leptin applied (0.3–50 nm). Control experiments using identical recording conditions but where no leptin was added to the bathing solution demonstrated that no spontaneous alterations of resting membrane potential occurred during time of recording (Fig. 1A). Examination of the voltage-clamped macroscopic currents (Fig. 1C and D) show that prior to leptin application (10 nm), the control slope conductance of the cells was 0.48 ± 0.18 nS, and following exposure to leptin a current was activated that displayed no voltage or time dependent properties, and resulted in a linear current-voltage relationship with a slope conductance of 2.7 ± 0.6nS (n= 6; P < 0.05). Essentially identical data were obtained for membrane potential (final values of −69 ± 4.2 and −71 ± 1.7 mV) and slope conductance (final values of 3.9 ± 1.0 and 4.3 ± 0.8 nS) on application of 1 ml (n= 5) and 3 ml (n= 9) leptin, respectively. The reversal potential associated with the increase in cell conductance for all three concentrations of leptin was essentially identical, and the mean pooled value was −79 ± 0.9 mV (n= 20), consistent with leptin causing the activation of a potassium current (the calculated reversal potential for a pure potassium channel under the conditions of our experiments is −84 mV). The lowest concentration of leptin that induced a hyperpolarization (from −40 to −62 mV) associated with a concomitant increase in potassium conductance of these cells was 0.3 nm (n= 1/3 tested).
This experiment was repeated but with omission of ATP from the electrode (and therefore the cell interior), allowing the cell to hyperpolarize slowly with a concomitant increase in cell conductance as the ATP is washed out of the cell interior and KATP channels are opened (Fig. 2A). Addition of leptin to the bathing solution following run-up of the KATP conductance resulted in no significant (P > 0.05; paired t test) increase in total conductance; mean slope conductance following run-up was 9.0 ± 2.3 nS and in the presence of leptin (3–10 nm), the slope conductance was 10.1 ± 2.8 nS (n= 4). In addition, it was noted that even in the constant presence of leptin, the KATP conductance slowly decreased with time (‘run-down’), resulting in a slow depolarization of the cell resting membrane potential (Fig. 2A). The hyperglycaemic agent diazoxide hyperpolarizes insulin-secreting cells by activating KATP currents (Trube, Pvorsman & ohno-Shosaku, 1986; Sturgess, Kozlowski, Carrington, Hales & Ashford, 1988), an action that is also dependent on the presence of intracellular nucleotides (Kozlowski & Ashford, 1992). Diazoxide (200 μm) stimulated an increase in KATP current with 5 mm ATP in the electrode solution (Fig. 2B) resulting in hyperpolarization of CBI-G1 cells from −39 ± 1.8 to −66 ± 1.3 mV with an associated increase in cell slope conductance from 0. 0, to 9.79 ± 0.95nS (n= 5). The reversal potential associated with diazoxide action was −79 ± 1.0 mV (n= 5). Following activation of KATP current by diazoxide, leptin (10 nm) was unable (P > 0.05) to increase the membrane potential or slope conductance (10.20 ± 0.83 nS) further. However, the increased KATP current and hyperpolarization associated with the action of diazoxide was reversed, in the presence of leptin (Fig. 2B), by application of 100 μm tolbutamide (n= 3). Thus leptin is incapable of eliciting the activation of a potassium conductance at a time when the KATP current is maximal in the absence of intracellular ATP or in the presence of ATP but following stimulation by diazoxide. These data are consistent with the KATP channel as the potassium channel type activated by leptin in these cells. Further evidence to substantiate this proposal was obtained from pharmacological examination of the potassium current induced by leptin.
Following leptin-induced (3 nm) cell hyperpolarization, application of TEA (1 mm), which in insulin-secreting cells does not inhibit KATP channels at concentrations that block voltage- and calcium-gated K+ channels (Ashcroft & Borsman, 1991), did not cause cell depolarization (n= 4) consistent with KATP channel activation. However, the leptin response was sensitive to the application of the sulphonylureas, tolbutamide and glibenclamide, purported selective blockers of KATP channels. The addition of tolbutamide (100 μm) to CRI-G1 cells in the presence of 3 nm leptin (following completion of the hyperpolarization and conductance increase) induced an immediate and complete reversal of the effects of leptin (Fig. 3A), such that the membrane potential returned to a value indistinguishable from the membrane potential prior to leptin activation (approximately −40 mV). The leptin-induced increase in cell conductance also reverted to control values in the presence of tolbutamide (Fig. 3B) and the reversal potential for this action was −77 ± 1.3 mV (n= 6). Removal of tolbutamide elicited a complete recovery of leptin-induced hyperpolarization and conductance (Fig. 3A). In similar experiments, application of glibenclamide (0.5 μm) also reversed the actions of leptin completely, causing a recovery of the membrane potential (approximately −40 mV; n= 8) and conductance (reversal potential was −79 ± 2.1 mV for current blocked by leptin, indicating that it was carried by potassium ions) to pre-leptin values (data not shown). However, in contrast to the effects of tolbutamide (a first generation sulphonylurea), glibenclamide (a second generation sulphonylurea) action was not recoverable on washout. In addition, concomitant addition of leptin (3 nm) with tolbutamide (100 μm) prevented leptin from inducing a hyperpolarization or increase in potassium current (n= 6; Fig. 3C).
Identification of the KATP channel as the molecular target for acute leptin action in these cells was obtained from single-channel recordings. Application of leptin (1-10 nm) to the bath during cell-attached recordings (with no leptin in the electrode solution) did not induce activation of KATP channel currents (n= 5). However, cell-attached recordings with 3 nm leptin in the electrode solution and no bath-applied leptin induced an increase in the activity of single potassium channels on ten out of thirteen occasions. There was a delay of approximately 5–20 min following formation of the cell-attached configuration before leptin-induced potassium channel activation occurred (Fig. 4B and C). Analysis of total channel current (over a 60 s period), 1 min after formation of the cell-attached configuration, resulted in a mean current of 0.59 ± 0.21 pA and this increased in the presence of 3 nm leptin, after 17–20 min to 3.40 ± 0.98pA (n= 6; P < 0.05). Identical control experiments in the absence of leptin (e.g. Fig. 4A and C) resulted in no KATP channel activation with mean currents of 0.10 ± 0.01 and 0.11 ± 0.04 pA (n= 3; P > 0.05) at the same time periods, respectively, Once activated, channel activity continued for the duration of recordings and activity could be inhibited reversibly by the application of 100 μm tolbutamide (n= 5; Fig. 5) or non-reversibly by 0.5 μm glibenclamide (data not shown) to the bathing solution during the cell-attached recording configuration. Furthermore, following leptin induction of channel activity in the cell-attached recording configuration, patches were subsequently excised into the inside-out configuration, where the potassium channel activity was shown to be completely inhibited by 1 mm ATP (n= 4; data not shown). Thus the sulphonylurea and ATP sensitivity of the single channels activated by leptin is consistent with KATP of insulin-secreting cells (Ashcroft & Ashcroft, 1990). In contrast, application of 3 nm leptin to the extracellular aspect of outside-out membrane patches did not cause activation of KATP channel activity (n= 11), regardless of the concentration of pipette ATP (0.25-5.0 mm) or calcium (0.1 or 1 μm), although channel activity present in patches with lowered internal ATP displayed tolbutamide sensitivity (data not shown).
Previous studies have shown that recombinant leptin decreases the plasma insulin and glucose levels in ob/ob (but not lean) mice (Pelleymounter et al. 1995), an action unlikely to be secondary to weight loss or reduced food intake (Levin, Nelson, Gurney, Vandlen & De Sauvage, 1996). More recently, recombinant leptin has been shown to inhibit glucose-stimulated insulin secretion by isolated islets from ob/ob and wild-type mice (Emilsson et al. 1997). our present data are consistent with leptin acting to decrease the release of insulin from pancreatic β-cells through the activation of KATP channels resulting in β-cell hyper-polarization and decreased cell excitability. The hyper-glycaemic agent diazoxide (Sturgess et al. 1988) also acts to hyperpolarize insulin-secreting cells and decrease excitability, but its actions are reversible and more rapid in comparison with leptin. Activation of KATP channel current by diazoxide in this cell line also occludes the effect of leptin on K+ conductance. Consequently, the identification of KATP channels as a molecular target for leptin action on CRI-G1 cells relies on three pieces of evidence: (1) that full activation of KATP currents, either by removal of intra-cellular ATP or by activation with the hypoglycaemic agent diazoxide, prevents the leptin-induced potassium current increase, (2) the sulphonylureas tolbutamide and glibenclamide (purported selective KATP channel inhibitors; Ashcroft & Ashcroft, 1992) reverse or prevent leptin-induced potassium current activation and cell hyper-polarization; and (3) identification of the channel activated by leptin as a sulphonylurea-sensitive ATP-inhibited K+ channel by single-channel recordings.
Leptin opened KATP channels during cell-attached recordings only when the protein was present in the electrode solution and therefore in direct contact with the extracellular domain of the membrane patch. This result suggests that leptin, presumably following binding to a high-affinity receptor site (Keiffer et al. 1996), probably opens KATP channels in a membrane-delimited manner, although formation of the outside-out configuration ablates this effect. Leptin receptors belong to the class I cytokine receptor family (Tartaglia et al. 1995) and recently another member of this family, the prolactin receptor, was demonstrated to couple to large conductance calcium-activated K+ channels stably transfected into Chinese hamster ovary cells (Prevarskaya, Skryma, Vacher, Daniel, Djiane & Dufy, 1995) in a membrane-delimited manner. This class of cytokine receptor is considered to act through the Janus protein tyrosine kinase (JAK) and signal transducers and activators of transcription (STAT) signal transduction pathways, and there is evidence that leptin receptor activation does use these pathways. However, further experiments are required to determine whether leptin receptor coupling to the KATP channel in insulin-secreting cells is via tyrosine kinase phosphorylation, as reported for the prolactin receptor (Prevarskaya et al. 1995). The concentrations of leptin shown to activate KATP channels in the present study are generally less than that reported for significant inhibition of insulin release (Emilsson et al. 1997), but certainly within the range reported in human plasma (0.3-3 nm; Caro, Sinha, Kolaczynski, Zhang & Considine, 1996).
There is now good evidence to suppose that there is a feedback loop between adipose tissue and pancreatic β-cells. Administration of insulin to mice increases leptin expression in adipose tissue and administration of leptin clearly reduces plasma insulin levels. There is also a positive correlation between the mass of adipose tissue and leptin levels (Caro et al. 1996). Therefore increased adipose mass will result in raised plasma leptin levels and this in turn will feed back to pancreatic β-cells to inhibit insulin secretion, via stimulation of KATP channels, and so result in reduced anabolism. However in the obese state this feedback loop is considered to be dysfunctional. In diet-induced obese animals, higher doses of leptin are required to induce weight loss (Campfield et al. 1995) and studies in humans have indicated that the majority of human obese subjects are hyperleptinaemic (Sinha et al. 1996). Furthermore, there is no evidence for a defect in leptin production or in the leptin receptor in humans (Considine et al. 1996; Maffei et al. 1996). Consequently, leptin resistance at a site downstream from the receptor may be an important factor in the aetiology of human obesity and diabetes mellitus. Hence further studies on leptin receptor KATP channel transduction mechanisms may help to elucidate the nature of these defects.
- 1990). Properties and functions of ATP-sensitive K-channels. Cellular Signalling 2, 197–214.DOI: 10.1016/0898-6568(90)90048-F & (
- 1992). The sulphonylurea receptor. Biochimica et Biophysica Acta 1175, 45–59.DOI: 10.1016/0167-4889(92)90008-Y & (
- 1991). The electrophysiology of the pancreatic β-cell. Progress in Biophysics and Molecular Biology 54, 87–143.DOI: 10.1016/0079-6107(89)90013-8 & (
- 1995). Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269, 546–549. , , , & (
- 1996). Leptin: the tale of an obesity gene. Diabetes 45, 1455–1462. , , , & (
- 1986). Five new insulin-producing cell lines with differing secretory properties. Journal of Endocrinology 109, 193–200. , , & (
- 1996). Mutation screening and identification of a sequence variation in the human ob gene coding. Biochemical and Biophysical Research Communications, 220, 735–739. , , , , , , , , , & (
- 1997). Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion. Diabetes 46, 313–316. , , , & (
- 1995). Weight reducing effects of the plasma protein encoded by the obese gene. Science 269, 543–546. , , , , , , , & (
- 1997). The effect of leptin is enhanced by microinjection into the ventromedial hypothalamus. Diabetes 46, 150–152. , , , , , , & (
- 1996). Leptin receptorss expressed on pancreatic β-cells. Biochemical and Biophysical Research Communications 224, 522–527.DOI: 10.1006/bbrc.1996.1059 , & (
- 1992). Nucleotide-dependent activation of KATP channels by diazoxide in CRI-G1 insulin-secreting cells. British Journal of Pharmacology 107, 34–43. & (
- 1996). Abnormal splicing of the leptin receptor in diabetic mice. Nature 379, 632–635.DOI: 10.1038/379632a0 , , , , , & (
- 1995). Characterization of an ATP-modulated large conductance Ca2+ -activated K+ channel present in rat cortical neurones. Journal of Physiology 488, 319–337. , & (
- 1996). Decreased food intake does not completely account for adiposity reduction after ob protein infusion. Proceedings of the National Academy of Sciences of the USA 93, 1726–1730.DOI: 10.1073/pnas.93.4.1726 , , , & (
- 1996). Absence of mutations in the human OB gene in obese/diabetic subjects. Diabetes 45, 679–682. , , , , , , , , , , & (
- 1995). Human obese gene expression: adipocyte-specific expression and regional differences in the adipose tissue. Diabetes 44, 855–858. , , , , , , , , , , , & (
- 1995). Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269, 540–543. , , , , , & (
- 1995). Role of tyrosine phosphorylation in potassium channel activation; functional association with prolactin receptor and JAK2 tyrosine kinase. Journal of Biological Chemistry 41, 24292–24299. , , , , & (
- 1996). Evidence of free and bound leptin in human circulation: studies in lean and obese subjects and during short-term fasting. Journal of Clinical Investigation 98, 1277–1282. , , , , , , , , & (
- 1995). The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377, 530–532.DOI: 10.1038/377530a0 , , , , , , , , , , , , , , , & (
- 1988). Effects of sulphonylureas and diazoxide on insulin secretion and nucleotide-sensitive channels in an insulin-secreting cell line. British Journal of Pharmacology 95, 83–94. , , , & (
- 1995). Identification and expression cloning of a leptin receptor, OB-R. Cell 83, 1263–1271. , , , , , , , , , , , , , , , , , & (
- 1986). opposite effects of tolbutamide and diazoxide on the ATP-dependent K+ channel in mouse pancreatic β-cells. Pflügers Archiv 407, 493–499. , & (
- 1994). Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425–432. , , , , & (
This work was supported by The Wellcome Trust (grant no. 042726), Pharmacia-Upjohn and the University of Aberdeen Research Committee (P. S.H). F. McK. is a Glaxo–Wellcome student. We thank Michelle Buchan for cell culture assistance.